Mark Larché

7PUBLICATIONS
36CO-AUTHORS
AllergyPowder and particle technologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 19, 2023
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.

Astrid L Voskamp, Sugandhika Khosa, Tracy Phan

|Jul 27, 2021
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence.

Oliver Pfaar, Jean Bousquet, Stephen R Durham

|May 24, 2021
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.

Oliver Pfaar, Karl-Christian Bergmann, Sergio Bonini

|May 12, 2019
Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.

Christopher D Rudulier, Elena Tonti, Eddie James

Pageof 2